MedTrace Logo

Supporting Effect of Dronabinol on Behavioral Therapy in Fibromyalgia and Chronic Back Pain

NCT00176163 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2010-02-02

No results posted yet for this study

Summary

It is known, that a so called "pain memory" usually evolves in chronic pain syndromes which both aggravates the disorder and modifies the patients pain perception. Thus, the principal object of pain therapy is to "delete" this dysfunctional pain memory. The combination of medication, physiotherapy and psychological therapy seems to be the most effective treatment. This study investigates the effect of a concomitant Dronabinol medication (Cannabinoid) on the effectiveness of behavioral therapy. It is hypothesized that the combination of behavioral therapy and Dronabinol will be most effective in deleting the pain memory.

Conditions

Interventions

BEHAVIORAL

Operant behavioral treatment; Drug: THC

Sponsors & Collaborators

  • Central Institute of Mental Health, Mannheim

    collaborator OTHER

  • University of Mannheim

    collaborator OTHER

  • Academic City Hospital, Germany

    collaborator OTHER

  • BG Trauma Center Ludwigshafen

    collaborator OTHER

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Justus Benrath, MD, PhD · Heidelberg University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Completion
2009-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00176163 on ClinicalTrials.gov